SAS

02.10.2023 • News

AstraZeneca, SAS Team up on AI and Analytics in Clinical Trials

AI and analytics software company SAS is collaborating with global biopharmaceutical company AstraZeneca to increase efficiency and drive automation in the delivery of statistical analyses for clinical and post-approval submissions to regulatory authorities.

17.05.2011 • News

DuPont Says $6.4 Billion Danisco Takeover In The Bag

19.04.2010 • News

Impact of Volcanic Ash Cloud on Europe

Top-Feature

Brenntag SE

A successful concept on course for expansion — maintenance Munich 2025

Free Expert Insights

Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

AstraZeneca

DuPont Company

SAS

AstraZeneca, SAS Team up on AI and Analytics in Clinical Trials

DuPont Says $6.4 Billion Danisco Takeover In The Bag

Impact of Volcanic Ash Cloud on Europe

Top-Feature

Brenntag Downsizes Management Board, Retains Both Divisions

Dual‑Targeting Breakthroughs: Advancements in Bispecific Antibody Development

Advanced Recycling Conference 2025: New Paths to the Circular Economy

20 Years of CHEManager International

ECA Foundation Aims to Become Largest Pharma Association for GMP/GDP Compliance

A successful concept on course for expansion — maintenance Munich 2025

Free Expert Insights

Dual‑Targeting Breakthroughs

Newsletter & e-edition